These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9628)

  • 1. The properties of beta-adrenoceptor antagonists.
    Shanks RG
    Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of intravenous beta-blocking drugs in coronary heart disease.
    Taylor SH; Silke B; Nelson GI
    J Pharmacol; 1983; 14 Suppl 2():157-67. PubMed ID: 6138465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH; Silke B; Lee PS
    N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
    Shand DG
    Circulation; 1983 Jun; 67(6 Pt 2):I2-5. PubMed ID: 6133642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic properties and therapeutic use of beta adrenergic receptor blocking drugs].
    Shanks RG
    Medicina (B Aires); 1979; 39 Suppl 1():87-99. PubMed ID: 45034
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN; Saul PA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the treatment of angina: a review.
    Prichard BN
    Postgrad Med J; 1976; 52 Suppl 4():35-41. PubMed ID: 787954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA
    Clin Physiol Biochem; 1990; 8 Suppl 2():18-27. PubMed ID: 1982758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacology of beta adrenergic blocking agents].
    Toyama S; Suzuki K
    Nihon Rinsho; 1973 Sep; 31(9):2687-95. PubMed ID: 4148964
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E; Heikkilä J
    Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings].
    Harry JD; Knapp MF; Linden RJ; Newcombe CP; Stoker JB
    Br J Clin Pharmacol; 1975 Aug; 2(4):374P. PubMed ID: 9951
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenergic blockade in some cardiovascular diseases.
    Tarazi RC
    Cardiovasc Clin; 1975; 7(1):173-85. PubMed ID: 238741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.